Bradley & Co Private Wealth Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.92K Hold
14
﹤0.01% 159
2025
Q4
$4.58K Hold
14
﹤0.01% 159
2025
Q3
$3.95K Hold
14
﹤0.01% 163
2025
Q2
$3.91K Hold
14
﹤0.01% 156
2025
Q1
$4.36K Hold
14
﹤0.01% 147
2024
Q4
$3.65K Buy
+14
New +$4.15K ﹤0.01% 149
2024
Q2
$4.37K Hold
14
﹤0.01% 142
2024
Q1
$3.98K Hold
14
﹤0.01% 149
2023
Q4
$4.03K Hold
14
﹤0.01% 156
2023
Q3
$3.76K Hold
14
﹤0.01% 138
2023
Q2
$3.11K Hold
14
﹤0.01% 147
2023
Q1
$3.38K Hold
14
﹤0.01% 144
2022
Q4
$3.68K Hold
14
﹤0.01% 144
2022
Q3
$3K Hold
14
﹤0.01% 154
2022
Q2
$3K Buy
+14
New +$3.43K ﹤0.01% 159

Other funds holding AMGN

Bradley & Co Private Wealth Management's AMGN Position: Q1 2026 in Review

Bradley & Co Private Wealth Management held its Amgen (AMGN) position steady in Q1 2026 at 14 shares worth $4.92K. The position accounts for ﹤0.01% of the portfolio, ranked #159.

Bradley & Co Private Wealth Management first reported a position in AMGN in Q2 2022 and has held it in 15 quarters since. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Bradley & Co Private Wealth Management held 14 shares of Amgen worth $4.92K as of Q1 2026.
  • Bradley & Co Private Wealth Management left its Amgen share count unchanged in Q1 2026.
  • Amgen made up ﹤0.01% of Bradley & Co Private Wealth Management's portfolio in Q1 2026, its #159 holding.
  • Bradley & Co Private Wealth Management first reported a position in Amgen in Q2 2022 and has held it in 15 quarters since.
  • 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Bradley & Co Private Wealth Management's 13F filing for Q1 2026, filed 13 May 2026.